parkinson's center sarasota using glutathione and functional neurology Abstracts - 2018 - Movement Disorders Clinical Trials for Parkinson's Disease

To establish connection with the NO-system, L-NAME (5.0 mg/kg) (worsening) and L-arginine (200.0 mg/kg) (effective only with blunted NO-synthesis, but not alone) were given intraperitoneally alone or in combination (d-arginine 200.0 mg/kg was not effective, data not shown)

Thus, a rapid, efficient host reaction may result in early elimination of viruses and no obvious disease symptoms (extreme resistance)

nitric-oxide signaling

doi: 10.3389/fonc.2022.922838 348

Replenishing glutathione is a foundational priority.* Liposomal delivery is the only practical way to achieve meaningful cellular glutathione elevation with an oral supplement.*

That's both the opportunity and the trap: at these prices, the cost difference between a well-tested vial and a poorly tested one is trivial, so there's no reason to accept anything less than a verified COA